Centrus Energy Corp. 10-Q Summary: Quarter Ended June 30, 2026
Business Context and Reporting Period
This summary covers the unaudited quarterly report (Form 10-Q) for Centrus Energy Corp. for the period ended June 30, 2026. Centrus operates two primary segments: LEU (Low-Enriched Uranium), supplying nuclear fuel components to commercial utilities, and Technical Solutions, providing uranium enrichment and technical services to the U.S. government and private sector. The company is heavily focused on the deployment of domestic High-Assay Low-Enriched Uranium (HALEU) production capabilities at its Piketon, Ohio facility.
Key Financial Metrics
| Metric (in millions) | Q2 2026 | Q2 2025 | 6M 2026 | 6M 2025 |
|---|---|---|---|---|
| Total Revenue | $176.1 | $154.5 | $252.8 | $227.6 |
| Gross Profit | $49.9 | $53.9 | $81.4 | $86.8 |
| Operating Income | $10.4 | $33.5 | $11.2 | $54.0 |
| Net Income | $16.8 | $28.9 | $26.8 | $56.1 |
| Diluted EPS | $0.77 | $1.59 | $1.21 | $3.22 |
| Cash & Equivalents | $1,868.5 (as of June 30, 2026) | |||
| Long-Term Debt | $1,177.5 (as of June 30, 2026) |
Segment Performance (Q2 2026):
- LEU Segment: Revenue of $153.4 million (up 22% YoY) driven by uranium sales ($53.4M), though SWU volume decreased 23%.
- Technical Solutions: Revenue of $22.7 million (down 21% YoY) with a gross loss of $1.7 million, primarily due to the HALEU Operation Contract.
Material Changes vs. Prior Period
- Profitability Decline: Net income decreased 42% in Q2 and 52% over the six months compared to the prior year. This was driven by a significant increase in Advanced Technology Costs (up 227% in Q2 to $10.8M) related to expansion projects and a $17.2M non-cash stock compensation charge from reclassifying Board RSUs from equity to liability.
- Investment Income Surge: Investment income increased 104% in Q2 to $16.3M, offsetting some operating declines, due to higher cash balances from recent debt and equity issuances.
- Capital Expenditures: Investing cash outflows spiked to $94.8 million for the six months ended June 30, 2026, compared to $5.7 million in the prior year, reflecting heavy investment in the Piketon and Oak Ridge expansion.
- Debt Structure: The company redeemed all 8.25% Notes in March 2025. Current long-term debt consists of $402.5M in 2.25% Convertible Notes (due 2030) and $805.0M in 0% Convertible Notes (due 2032).
Guidance, Outlook, and Risks
Outlook and Contracts:
- HALEU Expansion: On July 1, 2026, Centrus signed a $900 million task order with the DOE to expand commercial-scale HALEU production in Piketon, Ohio, with options for an additional $170 million. The company is also pursuing a joint venture with Oklo Inc. for HALEU deconversion services.
- Backlog: Total backlog stands at $4.5 billion ($3.7B LEU, $0.8B Technical Solutions). However, the DOE has indicated it does not currently intend to exercise further options under the existing HALEU Operation Contract beyond the current period, creating uncertainty for the $0.8B Technical Solutions backlog.
- Government Funding: The company relies on DOE funding for HALEU operations. The FY2027 budget proposal does not include funding for the current cascade operation, necessitating new commercial agreements.
Risks and Contingencies:
- Geopolitical Supply Chain: Operations are heavily dependent on the TENEX Supply Contract for Russian LEU. The U.S. Import Ban Act and Russian Decree require specific waivers and licenses. While waivers have been granted through 2027, future availability is uncertain.
- Legal Proceedings: Multiple class-action lawsuits regarding alleged contamination at the Portsmouth GDP site are ongoing. The company asserts indemnification under the Price-Anderson Act but cannot estimate potential liability.
- Liquidity: While cash reserves are strong ($1.9B), the company anticipates significant capital requirements for expansion and may require additional equity or debt financing, which could result in dilution.
Key Facts for Investor Verification
- DOE Funding Continuity: Verify the status of DOE appropriations for the HALEU Operation Contract beyond September 2026 and the likelihood of securing the $900M expansion task order funding.
- TENEX Waivers: Confirm the status of pending DOE waivers for Russian LEU imports for 2026-2027 and the reliability of Russian export licenses under the Russian Decree.
- Expansion Capitalization: Assess the sufficiency of current cash reserves ($1.9B) against the projected "several hundred million" in capital expenditures for the Piketon and Oak Ridge expansions.
- Non-GAAP Adjustments: Review the reconciliation of GAAP to Adjusted Net Income, specifically the $17.2M stock compensation charge and the classification of "Growth Costs" as non-recurring.
- Legal Exposure: Monitor developments in the Portsmouth GDP contamination lawsuits and the company's ability to secure Price-Anderson Act indemnification.